Stockscreener 앱 받기
1.15
1.77%
0.02
시간 외 거래:
1.15
Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스
EBIT per share of Phio Pharmaceuticals Corp. – BER:44R1 - TradingView
Will Phio Pharmaceuticals Corp. (44R1) stock beat revenue estimatesMarket Performance Summary & Risk Managed Trade Strategies - Newser
How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulationsJuly 2025 Selloffs & High Yield Equity Trading Tips - Newser
What technical patterns form on Phio Pharmaceuticals Corp. (44R1) stock chartsJuly 2025 Selloffs & High Yield Equity Trading Tips - Newser
Phio Pharmaceuticals Corp. (PHIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will Phio Pharmaceuticals Corp. (44R1) stock rise with strong economyWeekly Trend Summary & Weekly High Return Stock Opportunities - Newser
Phio Pharma (PHIO) Stock Analysis Report | Financials & Insights - Benzinga
How Phio Pharmaceuticals Corp. (44R1) stock compares with market leadersPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser
What insider trading reveals about Phio Pharmaceuticals Corp. stockProfit Target & Verified Swing Trading Watchlists - Newser
Can Phio Pharmaceuticals Corp. stock continue upward trendMarket Sentiment Report & Real-Time Volume Analysis - Newser
Phio Pharmaceuticals Completes Enrollment for PH-762 Trial - MSN
Why retail investors pile into Phio Pharmaceuticals Corp. stockLayoff News & Low Drawdown Trading Strategies - BỘ NỘI VỤ
MSN Money - MSN
How Phio Pharmaceuticals Corp. stock responds to policy changesMarket Risk Report & Fast Gain Swing Alerts - moha.gov.vn
TARC Limited Earnings Review What Investors Need to KnowMid Cap Growth Trends & Free Risk Assessment and Control - earlytimes.in
Phio Pharmaceuticals Completes Enrollment in Phase 1b Trial of PH-762 - TradingView
Phio Pharmaceuticals Corp. Announces Completion of Enrollment in Phase 1B Clinical Trial of Intasyl Sirna Lead Compound Ph-762 - marketscreener.com
Phio completes enrollment in Phase 1b trial of skin cancer therapy - Investing.com Australia
Phio completes enrollment in Phase 1b trial of skin cancer therapy By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762 - Newsfile
Phio Pharmaceuticals (NASDAQ: PHIO) Reports PH-762 Data With 6 Complete Responses - Stock Titan
[Form 4] Phio Pharmaceuticals Corp. Insider Trading Activity - Stock Titan
It is Poised to be a Bull Market for Phio Pharmaceuticals Corp (PHIO) - Setenews
What is HC Wainwright’s Forecast for PHIO FY2025 Earnings? - Defense World
How higher bond yields impact Phio Pharmaceuticals Corp. (44R1) stockJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
Developing predictive dashboards with Phio Pharmaceuticals Corp. dataQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com
Phio Pharmaceuticals Corp files for offering of up to 11.8 million common shares by the Selling StockholdersSEC filing - MarketScreener
[S-3] Phio Pharmaceuticals Corp. Shelf Registration Statement | PHIO SEC FilingForm S-3 - Stock Titan
How Phio Pharmaceuticals Corp. (44R1) stock trades under stagflationMarket Activity Recap & AI Optimized Trade Strategies - newser.com
Published on: 2025-11-20 05:56:20 - newser.com
How Phio Pharmaceuticals Corp. stock performs in rate cut cyclesPortfolio Value Summary & Real-Time Stock Entry Alerts - newser.com
Is Phio Pharmaceuticals Corp. (44R1) stock protected from inflationJuly 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock trades in high volatilityEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com
Published on: 2025-11-19 20:52:55 - newser.com
Published on: 2025-11-19 18:13:16 - newser.com
Published on: 2025-11-19 16:59:54 - newser.com
Published on: 2025-11-19 16:50:52 - newser.com
How Phio Pharmaceuticals Corp. (44R1) stock correlates with oil marketsDay Trade & Free Risk Controlled Daily Trade Plans - newser.com
Insider Buying: Robert Bitterman Acquires Additional Shares of P - GuruFocus
Bitterman buys Phio Pharmaceuticals (PHIO) stock worth $6350 By Investing.com - Investing.com Canada
Bitterman buys Phio Pharmaceuticals (PHIO) stock worth $6350 - Investing.com India
1.50%
자본화:
|
볼륨(24시간):